CD31 regulates metastasis by inducing epithelial–mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway
Authors:
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 429, 29-40
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81472224, 81672326)
- Ministry of Science and Technology of China (2015CB554005)
- Leading Investigator Program of Shanghai (17XD1401100)
This publication has 51 references indexed in Scilit:
- Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacitiesBMC Cancer, 2013
- Regulatory networks defining EMT during cancer initiation and progressionNature Reviews Cancer, 2013
- Transdifferentiation of glioblastoma cells into vascular endothelial cellsProceedings of the National Academy of Sciences, 2011
- Human Hepatocellular Carcinoma Tumor–derived Endothelial Cells Manifest Increased Angiogenesis Capability and Drug Resistance Compared with Normal Endothelial CellsClinical Cancer Research, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinomaJournal of Hepatology, 2007
- Platelet‐endothelial cell adhesion molecule‐1 (CD31) recycles and induces cell growth inhibition on human tumor cell linesJournal of Cellular Biochemistry, 2006
- Laminin-5 With Transforming Growth Factor-β1 Induces Epithelial to Mesenchymal Transition in Hepatocellular CarcinomaGastroenterology, 2005
- A decade?s studies on metastasis of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2003
- Changes in expression of the cell adhesion molecule PECAM‐1 (CD31) during differentiation of human leukemic cell linesTissue Antigens, 1994